Lennard P. L. Gilissen
Department of Gastroenterology and Hepatology
University Hospital Maastricht
Maastricht
Netherlands
Name/email consistency: high
- Pancytopenia due to high 6-methylmercaptopurine levels in a 6-mercaptopurine treated patient with Crohn's disease. Gilissen, L.P., Derijks, L.J., Verhoeven, H.M., Bierau, J., Hooymans, P.M., Hommes, D.W., Engels, L.G. Dig. Liver. Dis (2007)
- Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects?. Gilissen, L.P., Derijks, L.J., Driessen, A., Bos, L.P., Hooymans, P.M., Stockbrügger, R.W., Engels, L.G. Dig. Liver. Dis (2007)
- The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients. Gilissen, L.P., Bierau, J., Derijks, L.J., Bos, L.P., Hooymans, P.M., van Gennip, A., Stockbrügger, R.W., Engels, L.G. Aliment. Pharmacol. Ther. (2005)
- Some cases demonstrating the clinical usefulness of therapeutic drug monitoring in thiopurine-treated inflammatory bowel disease patients. Gilissen, L.P., Derijks, L.J., Bos, L.P., Verhoeven, H.M., Bus, P.J., Hooymans, P.M., Engels, L.G. Eur. J. Gastroenterol. Hepatol (2004)